Alkermes plc. Public Float
Alkermes plc. (ALKS) had Public Float of $4.66 billion as of 2025-06-30, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-25
- 2025-06-30: Entity Public Float $4.66B.
- 2024-06-30: Entity Public Float $3.94B.
- 2023-06-30: Entity Public Float $4.79B.
- 2022-06-30: Entity Public Float $4.84B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $4.66B 10-K · filed 2026-02-25 |
| 2024-06-30 | $3.94B 10-K · filed 2025-02-12 |
| 2023-06-30 | $4.79B 10-K · filed 2024-02-21 |
| 2022-06-30 | $4.84B 10-K/A · filed 2023-04-26 |
| 2021-06-30 | $3.92B 10-K/A · filed 2022-04-29 |
| 2020-06-30 | $3.06B 10-K/A · filed 2021-04-29 |
| 2019-06-30 | $3.51B 10-K · filed 2020-02-13 |
| 2018-06-30 | $6.32B 10-K · filed 2019-02-15 |
| 2017-06-30 | $8.82B 10-K · filed 2018-02-16 |
| 2016-06-30 | $6.49B 10-K · filed 2017-02-17 |
| 2015-06-30 | $9.53B 10-K · filed 2016-02-25 |
| 2014-06-30 | $7.28B 10-K · filed 2015-02-24 |
| 2013-06-28 | $3.85B 10-KT · filed 2014-02-27 |
| 2013-03-31 | $2.71B 10-K · filed 2013-05-23 |
| 2011-09-30 | $1.95B 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |